GENSCRIPT BIO

Forecast & Rating7 analysts currently cover GENSCRIPT BIO, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$44.95, about 28.4% upside from the current price of HK$35.02. Price targets range from HK$30.00 to HK$87.98 — a wide spread, showing clear disagreement over just how much GENSCRIPT BIO can rise. Historically, about 25.4% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study GENSCRIPT BIO closely still see room for the stock to rise. Data as of Oct 31, 2026; for reference only and not investment advice.